3 research outputs found
A casemix: congestive heart failure readmission rate and its associated factors in a tertiary teaching hospital in Kuala Lumpur
Cardiovascular mortality is within the top five causes of death from non-communicable disease based on World Health Organization profile. Around 20% of heart failure patients are readmitted within 30 days worldwide. Readmission within 30 days for congestive heart failure often related to non-compliant to fluid restriction, natural progression of the disease or pre-mature discharge. The study aims to evaluate the 30 days readmission rate of congestive heart failure in Universiti Kebangsaan Malaysia Medical Centre (UKMMC) from the year 2016-2017 using casemix data and to determine the associated factors related to it. Based on the data coding, cost of readmission incurred was calculated. The 30-days readmission rate of heart failure to UKMMC in the year 2016-2017 was 53.5% & 43.5%, higher than the developed countries standard but similar to that of local teaching hospitals. After adjustment, age and level of severity are the only significant associated factors for the 30-days readmission rate. Shorter average length of stay (ALOS) & lower extra-tariff were achieved for readmission of heart failure. Total of RM80,329.73 was saved in the year 2017 from prompt treatment and comprehensive care plan of treating 19.3% level 3 severity patients at level 1 ALOS and tariff-cost. The 30-days readmission rate for heart failure in UKMMC was comparable to local teaching hospitals. The reduction of 30-days readmission rate in 2017 saved much cost, shows good clinical governance and advanced treatment strategy. Casemix can be used to guide budget allocation for the cardiology department of UKMMC
Why can’t I see after my heart is fixed: a case series of ocular complications after cardiac intervention
Screening for premature coronary artery disease (CAD) using coronary artery calcium (CAC) score: a primary prevention pilot study
Acute Coronary Syndrome (ACS) events can be accelerated by positive family history
of young coronary artery disease (CAD). Risk factors assessment sometimes fail to
predict ACS occurrence. Additional investigations with coronary artery calcium
(CAC) score can be used independently in screening for primary prevention in
some population. This was a cross-sectional study in asymptomatic population
with first degree relatives (FDR) having premature CAD compared with a matched
population with no family history of CAD from September 2017 to March 2018 at
the Cardiology Clinic of Univeristi Kebangsaan Malaysia Medical Centre. A total
of 36 subjects were recruited with equal number in each group. Female were the
majority in each group (66.7%). The FDR group were slightly younger compared
to the control group [mean (SD) age 36.9 (4.9) against 38 (3.8), respectively). Both
groups represent high risk factors including overweight and obesity, abdominal
obesity as well as dyslipidemia. Newly diagnosed dyslipidemia was significant
in the group with family history (83.3% versus 44.4%, P<0.01). Both groups were
screened either into the low or moderate risk Framingham Risk Score group. CAC
score was higher in family history group (11.1% vs 0%, P>0.05). In conclusion,
CAC may be irrelevant for screening in younger population. However, the yield of
other risk factor is still alarming